Hybrid Closed Loop Therapy in Adults with Type 1 Diabetes
Hybrid Closed Loop Therapy in Adults with Type 1 Diabetes and Above-Target HbA1c: A Real-World Observational Study
Hybrid Closed Loop Therapy in Adults with Type 1 Diabetes and Above-Target HbA1c: A Real-World Observational Study
Members are very much encouraged to take part in our ongoing real world data collection from which we have learned so much (https://abcd.care/all-abcd-audit-publications).
ABCD, YDEF and Lilly have partnered to provide a virtual education programme for specialists working in diabetes.
The Diabetes Masterclass Educational Series has been organised and funded by Eli Lilly & Company, developed in partnership with ABCD and YDEF.
The webinar series provides regular updates on relevant topics to support those delivering diabetes services. Watch the webinar on-demand below.
Presented by Dr Emma Wilmot
These educational modules on Hybrid Closed Loops (HCL) feature the perspectives of healthcare professionals. The series gives an introduction to Hybrid Closed Loops and covers a range of relevant topics, including HCL Essentials, HCL Systems and Exercise, and Top Tips.